QIAGEN N.V. (QGEN:NYSE)
$41.68 0.79 (1.932%)
Analysed QIAGEN N.V. (QGEN:NYSE) News Sources
Qiagen (QGEN) Upgraded to Buy by Deutsche Bank After 30% Decline
02-04-2026
yahoo.com
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
01-04-2026
yahoo.com
Parse Biosciences, a QIAGEN Company, Launches FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis
31-03-2026
yahoo.com
Is New TB Data and AI Investment Altering The Investment Case For Qiagen’s QuantiFERON Platform (QGEN)?
24-03-2026
yahoo.com
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results
20-03-2026
yahoo.com
Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More
20-03-2026
yahoo.com
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
19-03-2026
yahoo.com
Hologic's Women's Health Index Flags Alarming Gaps in STI Screening
19-03-2026
yahoo.com
Assessing Qiagen (QGEN) Valuation After Recent Share Price Weakness
12-03-2026
yahoo.com
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
10-03-2026
yahoo.com
What is the current price of QIAGEN N.V. (QGEN:NYSE)?
The current price of QIAGEN N.V. (QGEN:NYSE) is $41.68.
QIAGEN N.V. (QGEN:NYSE) absolute price change since previous trading day?
The absolute price change of QIAGEN N.V. (QGEN:NYSE) since the previous trading day is $0.79.
QIAGEN N.V. (QGEN:NYSE) percentage price change since previous trading day?
The percentage price change of QIAGEN N.V. (QGEN:NYSE) since the previous trading day is 1.932%.
What is the most recent average sentiment score for QIAGEN N.V. (QGEN:NYSE)?
The most recent average sentiment score for QIAGEN N.V. (QGEN:NYSE) is 69 out of 100.
What is the most recent average sentiment for QIAGEN N.V. (QGEN:NYSE)?
The most recent sentiment for QIAGEN N.V. (QGEN:NYSE) is .
SEC-8K** Filing Available For QIAGEN N.V. (QGEN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.